Erasmus MC at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Erasmus MC brings 4 presentations to ESGCT 2026 in Hamburg. Its work centres on lentiviral gene therapy for inherited metabolic and neurological diseases, including a blood stem cell approach to a childhood neuronal disorder. Other strands cover open source tools for analysing vector integration and targeted nanoparticles.
| Organization | ESGCT 2026 Attendance |
|---|---|
Erasmus MC Rotterdam, Netherlands | |
University medical centre in Rotterdam, with gene therapy research for inherited diseases such as Pompe disease. | Poster Wed Oct 28 1:30pm–3:30pm Developing open source bioinformatic tools for the analysis of lentiviral integration and lentiviral mediated gene therapy efficacy / safety Poster Wed Oct 28 1:30pm–3:30pm Functional characterization of an MPS II mouse model Rare and inherited disease Poster Thu Oct 29 2:00pm–4:00pm Functionalised PLGA nanoparticle for cell-specific targeted delivery Poster Thu Oct 29 2:00pm–4:00pm Hematopoietic stem and progenitor cell-mediated lentiviral gene therapy for neuronal ceroid lipofuscinosis type 2 Chair Thu Oct 29 4:00pm–6:00pm SESSION 9c: Immunotherapy and CAR T cells III Cell therapies and CAR-T |
Instantly find 20 buyers from Erasmus MC
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction